-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We decrease our 12-month target price by $92 to $693, or 65.0x our 2027 EPS estimate, a discount relative to AXON's average forward P/E of 92.7x (during the trailing-12-month period). We trim our EPS estimates for 2026 by $0.16 to $7.78 and 2027's by $0.12 to $10.66. AXON's fundamental strength remains compelling as the company extends its competitive moat through an integrated ecosystem that combines hardware, cloud software, and AI capabilities. With 30%+ revenue growth for nine consecutive quarters, AXON is capitalizing on a $159 billion TAM while penetrating less than 15% of its core U.S. market. Multiple growth drivers are accelerating simultaneously: AI Era Plan bookings surged 140% Y/Y with near-universal adoption among large agencies; Dedrone counter-drone revenue jumped 300% Y/Y; and international revenue doubled, reaching 20% of total sales. Axon's 125% net revenue retention and $14.3 billion in future contracted bookings (+44% Y/Y) underscore strong visibility.